Elixir Capital Limited has issued a regulatory notice to BSE Limited regarding an upcoming Board of Directors meeting. The meeting is scheduled for Friday, 6th November, 2026, and will be held at the company's Registered Office.
The primary agenda items for the board meeting include:
- Approval and taking on record the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026
- Consideration of any other business with the permission of the Chair
The company previously intimated to the Exchange on 24th September, 2026 that the trading window for dealing in securities of the Company would remain closed from Thursday, 1st October, 2026 for the consideration of these financial results. The trading window will reopen 48 hours after the declaration of the Un-Audited Financial Results.
This notice is provided to the Exchange pursuant to Regulation 29(2) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The document is signed by Radhika Mehta, Whole-Time Director, and digitally signed by Radhika Dipan Mehta on 29th October, 2026 at 12:54:21 +05'30'.